102 related articles for article (PubMed ID: 15708732)
1. Progressive morphometric and cognitive changes in vascular dementia.
Gunstad J; Brickman AM; Paul RH; Browndyke J; Moser DJ; Ott BR; Gordon N; Haque O; Cohen RA
Arch Clin Neuropsychol; 2005 Mar; 20(2):229-41. PubMed ID: 15708732
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging correlates of dementia rating scale performance at baseline and 12-month follow-up among patients with vascular dementia.
Sweet LH; Paul RH; Cohen RA; Moser D; Ott BR; Gordon N; Browndyke JN; Shah P; Garrett KD
J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):240-4. PubMed ID: 14653434
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates of cognitive decline in vascular dementia.
Paul RH; Cohen RA; Moser DJ; Ott BR; Sethi M; Sweet L; Browndyke J; Malloy P; Garrett K
Cogn Behav Neurol; 2003 Mar; 16(1):40-6. PubMed ID: 14765000
[TBL] [Abstract][Full Text] [Related]
4. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
Cohen RA; Browndyke JN; Moser DJ; Paul RH; Gordon N; Sweet L
Cerebrovasc Dis; 2003; 16(3):199-204. PubMed ID: 12865605
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study.
Jokinen H; Kalska H; Ylikoski R; Madureira S; Verdelho A; van der Flier WM; Scheltens P; Barkhof F; Visser MC; Fazekas F; Schmidt R; O'Brien J; Waldemar G; Wallin A; Chabriat H; Pantoni L; Inzitari D; Erkinjuntti T;
Cerebrovasc Dis; 2009; 27(4):384-91. PubMed ID: 19276621
[TBL] [Abstract][Full Text] [Related]
6. Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD.
Erkinjuntti T
Int J Clin Pract Suppl; 2001 May; (120):14-23. PubMed ID: 11406922
[TBL] [Abstract][Full Text] [Related]
7. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
[TBL] [Abstract][Full Text] [Related]
8. Treatment of vascular dementia: evidence from trials with non-cholinergic drugs.
Pantoni L
J Neurol Sci; 2004 Nov; 226(1-2):67-70. PubMed ID: 15537523
[TBL] [Abstract][Full Text] [Related]
9. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
Jellinger KA
Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
[TBL] [Abstract][Full Text] [Related]
10. The enigma of vascular cognitive disorder and vascular dementia.
Jellinger KA
Acta Neuropathol; 2007 Apr; 113(4):349-88. PubMed ID: 17285295
[TBL] [Abstract][Full Text] [Related]
11. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
12. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
Meyer JS; Huang J; Chowdhury MH
J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
[TBL] [Abstract][Full Text] [Related]
13. Mild cognitive impairment after lacunar infarction: voxel-based morphometry and neuropsychological assessment.
Grau-Olivares M; Bartrés-Faz D; Arboix A; Soliva JC; Rovira M; Targa C; Junqué C
Cerebrovasc Dis; 2007; 23(5-6):353-61. PubMed ID: 17268166
[TBL] [Abstract][Full Text] [Related]
14. Understanding the pathology of vascular cognitive impairment.
Jellinger KA
J Neurol Sci; 2005 Mar; 229-230():57-63. PubMed ID: 15760620
[TBL] [Abstract][Full Text] [Related]
15. The relationship of subcortical MRI hyperintensities and brain volume to cognitive function in vascular dementia.
Cohen RA; Paul RH; Ott BR; Moser DJ; Zawacki TM; Stone W; Gordon N
J Int Neuropsychol Soc; 2002 Sep; 8(6):743-52. PubMed ID: 12240738
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
Steffens DC; Potter GG; McQuoid DR; MacFall JR; Payne ME; Burke JR; Plassman BL; Welsh-Bohmer KA
Am J Geriatr Psychiatry; 2007 Oct; 15(10):839-49. PubMed ID: 17623814
[TBL] [Abstract][Full Text] [Related]
17. Imaging of static brain lesions in vascular dementia: implications for clinical trials.
Erkinjuntti T; Bowler JV; DeCarli CS; Fazekas F; Inzitari D; O'Brien JT; Pantoni L; Rockwood K; Scheltens P; Wahlund LO; Desmond DW
Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S81-90. PubMed ID: 10609686
[TBL] [Abstract][Full Text] [Related]
18. Nimodipine in subcortical vascular dementia trial.
Rossi R; Inzitari D; Pantoni L; del Ser T; Erkinjuntti T; Wallin A; Bianchi C; Badenas JM; Beneke M
Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S159-65. PubMed ID: 10609696
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic spontaneous cerebral emboli predict cognitive and functional decline in dementia.
Purandare N; Voshaar RC; Morris J; Byrne JE; Wren J; Heller RF; McCollum CN; Burns A
Biol Psychiatry; 2007 Aug; 62(4):339-44. PubMed ID: 17531959
[TBL] [Abstract][Full Text] [Related]
20. Performance on the Hooper Visual Organizational Test in patients diagnosed with subcortical vascular dementia: relation to naming performance.
Paul R; Cohen R; Moser D; Ott B; Zawacki T; Gordon N
Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):93-7. PubMed ID: 11417672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
